OHSU and Legacy Health have mutually agreed to walk away from a deal that would have combined the two health systems. Last August, OHSU agreed to acquire Legacy's eight hospitals and $3 billion in assets, with a promise to spend $1 billion on upgrades to Legacy's facilities. "After careful consideration of the evolving operating environment, the organizations have determined that the best way to meet the needs of the communities they serve is to move forward as individual organizations," an OHSU spokesperson wrote in an email. The statement does not detail why the acquisition was called off. Leaders at Legacy and OHSU declined a request for an interview about the decision.
Two independent medical practices in Minnesota once hoped to expand operations but have spent the past year struggling to recover from the cyberattack on a vast UnitedHealth Group payment system. Odom Health & Wellness, a sports medicine and rehabilitation outfit, and the Dillman Clinic & Lab, a family medicine practice, are among the thousands of medical offices that experienced sudden financial turmoil last year. The cyberattack against Change Healthcare, a division of United, paralyzed much of the nation's healthcare payment system for months.
Longtime labor leader George Gresham was toppled by his former lieutenants in a contentious race to lead the nation's largest health care union. Gresham, who became president of 1199 SEIU United Healthcare Workers East in 2007, lost his reelection bid by a resounding margin to challenger Yvonne Armstrong, who leads the union's long-term care division.
Democratic attorneys general across 19 states and Washington, DC, have filed a lawsuit against HHS, HHS Secretary Robert F. Kennedy Jr. and other federal health officials, alleging that the agency's restructuring endangers the American public after several public health programs were dismantled and thousands of federal health workers fired in the process.
Americans spent $98 billion out of pocket on prescription drugs in 2024, marking a cumulative 25% increase over five years, according to an annual report from analytics firm IQVIA.
A bipartisan pair of senators introduced legislation to lower prescription drug prices by prohibiting pharmaceutical companies from selling drugs in the U.S. at higher prices than the international average.